# Viatris Inc: filings

VTRS · Nasdaq · CIK 1792044 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/vtrs.md) · [Financials](/companies/vtrs/financials.md) · [Filings](/companies/vtrs/filings.md) · [Insiders](/companies/vtrs/insiders.md)

## Reports and events: 110 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 279, 8-K 64, 3 34, 10-Q 20, 144 16, 8-K/A 8, CORRESP 8, DEFA14A 8, SCHEDULE 13G/A 8, 10-K 7, SC 13G/A 7, UPLOAD 7, DEF 14A 6, 10-K/A 5, 425 5, SC 13G 5, ARS 4, SCHEDULE 13G 4, 10-12G 3, S-4/A 3, SC TO-C 3, 10-12G/A 2, 424B3 2, 424B5 2, 5 2, EFFECT 2, RW 2, S-3ASR 2, S-4 2, S-8 2, SC TO-T/A 2, 3/A 1, 4/A 1, 8-A12B 1, CERT 1, FWP 1, PRE 14A 1, S-3 1, SC TO-T 1, SEC STAFF ACTION 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-08 | 08:38 ET | [8-K](/filings/0001140361-26-039024.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-039024 |
| 2026-08-06 | 16:04 ET | [10-Q](/filings/0001792044-26-000041.md) | Quarterly report, period 2026-06-30 | 0001792044-26-000041 |
| 2026-08-06 | 07:56 ET | [8-K](/filings/0001792044-26-000037.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001792044-26-000037 |
| 2026-07-01 | 16:20 ET | [8-K](/filings/0001140361-26-027216.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001140361-26-027216 |
| 2026-06-18 | 16:10 ET | [8-K](/filings/0001140361-26-025744.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001140361-26-025744 |
| 2026-06-15 | 16:32 ET | [8-K](/filings/0001140361-26-025228.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-025228 |
| 2026-05-15 | 16:30 ET | [8-K](/filings/0001140361-26-021672.md) | 5.07 Shareholder vote results | 0001140361-26-021672 |
| 2026-05-07 | 16:03 ET | [10-Q](/filings/0001792044-26-000029.md) | Quarterly report, period 2026-03-31 | 0001792044-26-000029 |
| 2026-05-07 | 07:47 ET | [8-K](/filings/0001792044-26-000025.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001792044-26-000025 |
| 2026-05-04 | 16:39 ET | [8-K](/filings/0001140361-26-018887.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-018887 |
| 2026-04-02 | 16:30 ET | [DEF 14A](/filings/0001140361-26-013002.md) | Proxy statement, period 2026-05-15 | 0001140361-26-013002 |
| 2026-02-26 | 16:26 ET | [10-K](/filings/0001792044-26-000013.md) | Annual report, period 2025-12-31 | 0001792044-26-000013 |
| 2026-02-26 | 07:52 ET | [8-K](/filings/0001792044-26-000010.md) | 2.02 Results of operations; 2.05 Exit or disposal costs; 8.01 Other events; 9.01 Financial statements and exhibits | 0001792044-26-000010 |
| 2026-02-03 | 16:30 ET | [8-K](/filings/0001140361-26-003477.md) | 5.02 Departure or appointment of officers or directors | 0001140361-26-003477 |
| 2025-12-08 | 07:00 ET | [8-K](/filings/0001140361-25-044706.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-25-044706 |
| 2025-12-05 | 16:18 ET | [8-K](/filings/0001140361-25-044544.md) | 5.07 Shareholder vote results | 0001140361-25-044544 |
| 2025-12-05 | 16:15 ET | [8-K/A](/filings/0001140361-25-044541.md) | 5.02 Departure or appointment of officers or directors | 0001140361-25-044541 |
| 2025-11-06 | 16:07 ET | [10-Q](/filings/0001792044-25-000046.md) | Quarterly report, period 2025-09-30 | 0001792044-25-000046 |
| 2025-11-06 | 07:53 ET | [8-K](/filings/0001792044-25-000042.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001792044-25-000042 |
| 2025-10-24 | 16:21 ET | [8-K](/filings/0001140361-25-039269.md) | 5.03 Amendment to articles or bylaws; 5.08 Item not in the standard list; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-039269 |
| 2025-10-24 | 16:15 ET | [DEF 14A](/filings/0001140361-25-039263.md) | Proxy statement, period 2025-12-05 | 0001140361-25-039263 |
| 2025-08-07 | 16:05 ET | [10-Q](/filings/0001792044-25-000033.md) | Quarterly report, period 2025-06-30 | 0001792044-25-000033 |
| 2025-08-07 | 07:58 ET | [8-K](/filings/0001792044-25-000031.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001792044-25-000031 |
| 2025-08-05 | 07:30 ET | [8-K](/filings/0001140361-25-028739.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-25-028739 |
| 2025-05-08 | 09:21 ET | [10-Q](/filings/0001792044-25-000018.md) | Quarterly report, period 2025-03-31 | 0001792044-25-000018 |
| 2025-05-08 | 07:53 ET | [8-K](/filings/0001792044-25-000016.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001792044-25-000016 |
| 2025-05-05 | 16:45 ET | [8-K](/filings/0001140361-25-017356.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-25-017356 |
| 2025-04-30 | 16:30 ET | [10-K/A](/filings/0001140361-25-016679.md) | Annual report, amended, period 2024-12-31 | 0001140361-25-016679 |
| 2025-02-27 | 16:07 ET | [10-K](/filings/0001792044-25-000008.md) | Annual report, period 2024-12-31 | 0001792044-25-000008 |
| 2025-02-27 | 07:38 ET | [8-K](/filings/0001792044-25-000004.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001792044-25-000004 |
| 2024-12-06 | 17:20 ET | [8-K](/filings/0001193125-24-272562.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001193125-24-272562 |
| 2024-11-07 | 16:11 ET | [10-Q](/filings/0001792044-24-000033.md) | Quarterly report, period 2024-09-30 | 0001792044-24-000033 |
| 2024-11-07 | 07:58 ET | [8-K](/filings/0001792044-24-000031.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001792044-24-000031 |
| 2024-10-25 | 16:35 ET | [DEF 14A](/filings/0001193125-24-244173.md) | Proxy statement, period 2024-12-06 | 0001193125-24-244173 |
| 2024-09-27 | 16:00 ET | [8-K](/filings/0000950157-24-001314.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0000950157-24-001314 |
| 2024-09-04 | 07:46 ET | [8-K](/filings/0000950157-24-001164.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950157-24-001164 |
| 2024-08-08 | 16:04 ET | [10-Q](/filings/0001792044-24-000025.md) | Quarterly report, period 2024-06-30 | 0001792044-24-000025 |
| 2024-08-08 | 08:03 ET | [8-K](/filings/0001792044-24-000022.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001792044-24-000022 |
| 2024-07-03 | 08:40 ET | [8-K](/filings/0001193125-24-174684.md) | 2.01 Completion of an acquisition or disposition | 0001193125-24-174684 |
| 2024-06-03 | 07:16 ET | [8-K](/filings/0001193125-24-152351.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-152351 |
| 2024-05-09 | 16:03 ET | [10-Q](/filings/0001792044-24-000017.md) | Quarterly report, period 2024-03-31 | 0001792044-24-000017 |
| 2024-05-09 | 07:44 ET | [8-K](/filings/0001792044-24-000014.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001792044-24-000014 |
| 2024-04-26 | 16:31 ET | [10-K/A](/filings/0001193125-24-118165.md) | Annual report, amended, period 2023-12-31 | 0001193125-24-118165 |
| 2024-02-28 | 16:15 ET | [10-K](/filings/0001792044-24-000008.md) | Annual report, period 2023-12-31 | 0001792044-24-000008 |
| 2024-02-28 | 07:39 ET | [8-K](/filings/0001792044-24-000004.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001792044-24-000004 |
| 2024-01-30 | 16:40 ET | [8-K/A](/filings/0001193125-24-019472.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-24-019472 |
| 2023-12-15 | 17:04 ET | [8-K/A](/filings/0001193125-23-296763.md) | 5.02 Departure or appointment of officers or directors | 0001193125-23-296763 |
| 2023-12-15 | 17:00 ET | [8-K](/filings/0001193125-23-296756.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-296756 |
| 2023-12-15 | 16:14 ET | [8-K](/filings/0001193125-23-296654.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-23-296654 |
| 2023-12-15 | 16:12 ET | [8-K](/filings/0001193125-23-296644.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-296644 |

Page 1 of 3. [Older](/companies/vtrs/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 07:41 ET. No prices; not investment advice.